556 related articles for article (PubMed ID: 25556828)
21. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
[TBL] [Abstract][Full Text] [Related]
22. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
23. Rapid complete regression of an early infantile hemangioma with topical timolol gel.
Semkova K; Kazandjieva J
Int J Dermatol; 2014 Feb; 53(2):241-2. PubMed ID: 24261914
[No Abstract] [Full Text] [Related]
24. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
[TBL] [Abstract][Full Text] [Related]
25. Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain.
Colmenero M; Del Boz J; Bernabeu Wittel J; Roé E; Feito-Rodríguez M; Vicente-Villa MA; Martín-Santiago A; Palencia Pérez SI; Azon A; Valdivielso-Ramos M; Torrelo A; Sánchez Moya AI; Campos-Domínguez M; Garnacho-Saucedo G; Azaña Defez JM; Vera Casaño Á; Tercedor-Sánchez J; Alcalá R; González-Enseyat MA; Giacaman A; Hernández-Martin Á; Monserrat García MT; Bauzá A; Domínguez-Cruz J; García-Doval I; Grau-Pérez M
Pediatr Dermatol; 2022 Jul; 39(4):557-562. PubMed ID: 35504688
[TBL] [Abstract][Full Text] [Related]
26. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Hu L; Huang HZ; Li X; Lin XX; Li W
Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
[TBL] [Abstract][Full Text] [Related]
27. Failure of intralesional propranolol in infantile hemangiomas.
Torres-Pradilla M; Baselga E
Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
[TBL] [Abstract][Full Text] [Related]
28. Current concepts in the management of periocular infantile (capillary) hemangioma.
Ni N; Guo S; Langer P
Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
[TBL] [Abstract][Full Text] [Related]
29. Propranolol for Surgeons in the Treatment of Infantile Hemangiomas.
Sinha S; Lloyd MS
J Craniofac Surg; 2020; 31(1):134-137. PubMed ID: 31688260
[TBL] [Abstract][Full Text] [Related]
30. Topical timolol for small hemangiomas of infancy.
Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
[TBL] [Abstract][Full Text] [Related]
31. Topical timolol for an iris hemangioma.
Gummi R; Stahl ED; Marsh JD
J AAPOS; 2018 Apr; 22(2):156-158. PubMed ID: 29412149
[TBL] [Abstract][Full Text] [Related]
32. [Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas].
Zheng JW; Wang XK; Jiang CH; Qin ZP; Fan XD; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK; Lei SR
Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):744-747. PubMed ID: 28275803
[TBL] [Abstract][Full Text] [Related]
33. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
34. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.
Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ
Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
36. Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution.
Rizvi SA; Yusuf F; Sharma R; Rizvi SW
Semin Ophthalmol; 2015 Jan; 30(1):62-4. PubMed ID: 24074395
[TBL] [Abstract][Full Text] [Related]
37. How should propranolol be initiated for infantile hemangiomas: inpatient versus outpatient?
Patel NJ; Bauman NM
Laryngoscope; 2014 Jun; 124(6):1279-81. PubMed ID: 24347141
[No Abstract] [Full Text] [Related]
38. Infantile hemangioma. Part 2: Management.
Sebaratnam DF; Rodríguez Bandera AL; Wong LF; Wargon O
J Am Acad Dermatol; 2021 Dec; 85(6):1395-1404. PubMed ID: 34419523
[TBL] [Abstract][Full Text] [Related]
39. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
40. [Effect of propranolol gel on infantile hemangiomas].
Zhai YN; Song HT; Chen SQ; Zhang MX; Li CJ; Xia Y; Wang L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jan; 29(1):25-8. PubMed ID: 23600126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
